Forecasting Stories
Sono Tek Corp (NASDAQ:SOTK), a technology company specializing in electronic equipment and instruments, has been a topic of interest among institutional investors. The company, which had its IPO on the 6th of May 1987, currently has a market valuation of $5.26 million and a valuation real value of $6.44 million. With a 200-day MA of 5.9046 and a 50-day MA of 5.3554, the stock has shown some volatility, but the overall analyst consensus remains a 'Strong Buy'.
over six months ago at Macroaxis By Gabriel Shpitalnik |
Daktronics, a leading player in the Electronic Equipment & Instruments industry, has seen its stock surge over 2% despite broader market gains, outperforming many of its peers. The company, which ended its fiscal year in May, has been on a positive trajectory with a 52-week high of $7.15 and a Wall Street target price of $8. Despite a loss of $0.18 per share estimated for the current year, analysts expect a strong turnaround with an EPS estimate of $0.71 for the next year.
over six months ago at Macroaxis By Aina Ster |
Cass Information Systems (NASDAQ: CASS), a prominent player in the Data Processing & Outsourced Services sector, is anticipated to experience a bullish trend in August 2023. As of July 10, 2023, the company has a P/E ratio of 15.7828 and a payout ratio of 0.4713, indicating a strong financial position. The Wall Street target price stands at $43, suggesting potential upside from the current valuation.
over six months ago at Macroaxis By Raphi Shpitalnik |
Greenidge Generation Holdings (USA Stocks: GREE) has been making waves in the stock market with a strong buy consensus from analysts. As of the 9th of July 2023, the company's shares short have increased to 289.1K from 219.9K in the prior month, indicating a heightened interest in the stock. Despite an estimated loss of $0.2 per share for the current quarter and $1.5 for the current year, the EPS estimate for the next year stands at a promising $2.3.
over six months ago at Macroaxis By Vlad Skutelnik |
Loop Industries (NASDAQ: LOOP), a key player in the Commodity Chemicals sector, is currently under Wall Street's microscope. Despite an EPS estimate for the current year reflecting a loss of $0.75, analysts have an overall consensus of 'Buy' for the stock. With an estimated target price of $7, the highest estimate reaches up to $8, suggesting a potential upside.
over six months ago at Macroaxis By Ellen Johnson |
Riley Exploration Permian (REPX) is a player in the Oil, Gas & Consumable Fuels sector, specifically in Oil & Gas Refining & Marketing. With a strong buy consensus from two analysts, the Wall Street target price stands at an impressive $58, indicating a potential upside price of $40.12 from its current valuation. The highest and lowest estimated target prices are $60 and $56 respectively, further reinforcing the positive outlook.
over six months ago at Macroaxis By Aina Ster |
Helen of Troy (NASDAQ: HELE), a prominent player in the Consumer Defensive sector, particularly in Household Durables, has been catching the eye of investors. As of July 8, 2023, the company's shares are shorted by 5.9 million, a decrease from 6 million the previous month. The company's PE Ratio stands at 18.3589, with a PEG Ratio of 1.3354, indicating potential growth.
over six months ago at Macroaxis By Vlad Skutelnik |
WW International, a key player in the Specialized Consumer Services sector, has been outperforming in the midst of a broader market downturn. Despite a loss of $1.85 EPS estimated for the current year, the company has shown resilience with a 52-week high of $10.02, significantly higher than its 52-week low of $3.28. Analysts hold varying opinions, with 4 estimates ranging from a low of $4 to a high of $13, and an average target price of $7.9.
over six months ago at Macroaxis By Gabriel Shpitalnik |
As of July 6, 2023, Tsakos Energy Navigation (TNP) is showing promising signs as a smart investment choice. The company, which operates in the Oil & Gas Storage & Transportation industry, has a strong buy consensus from analysts. The estimated target price stands at an optimistic $30, a substantial leap from the current market value of $18.7.
over six months ago at Macroaxis By Ellen Johnson |
Nurix Therapeutics Inc. (NRIX), a key player in the Biotechnology sector, is predicted to experience a bullish surge in August, according to several market analysts. Despite a loss of $3.04 per share estimated for the current year and a further expected loss of $3.39 for the next year, the company's stock is forecasted to reach a naive expected forecast value of $10.56. Currently, the company's 50-day moving average stands at $10.19, with a 200-day moving average of $11.06.
over six months ago at Macroaxis By Gabriel Shpitalnik |